<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9707608" created="06/04/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9707608</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="Epstein-Barr_virus-transforming_protein" sem="Protein_molecule">Epstein-Barr virus-transforming protein</term> <term id="T2" lex="latent_infection_membrane_protein_1" sem="Protein_molecule">latent infection membrane protein 1</term> activates <term id="T3" lex="transcription_factor_NF-kappaB" sem="Protein_complex">transcription factor <term id="T4" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term></term> through a <term id="A1" sem="Other">pathway</term> that includes the <term id="T5" lex="NF-kappaB-inducing_kinase" sem="Protein_molecule"><term id="T6" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>-inducing kinase</term> and the <term id="T7" lex="IkappaB_kinase" sem="Protein_family_or_group">IkappaB kinases</term> <term id="T8" lex="IKKalpha" sem="Protein_molecule">IKKalpha</term> and <term id="T9" lex="IKKbeta" sem="Protein_complex">IKKbeta</term>.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="T4"/>
<cause idref="T2"/>
<clue>Epstein-Barr virus-transforming protein latent infection membrane protein 1 <clueType>activates</clueType> transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.</clue>
</event>
<event id="E65">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="E66"/>
<clue>Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB <linkCause>through</linkCause> a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E69">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="E67"/>
<clue>Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB <linkCause>through</linkCause> a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E70">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="E68"/>
<clue>Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB <linkCause>through</linkCause> a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E66">
<type class="Correlation"/>
<theme idref="A1"/>
<theme idref="T5"/>
<clue>Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that <clueType>includes</clueType> the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.</clue>
</event>
<event id="E67">
<type class="Correlation"/>
<theme idref="A1"/>
<theme idref="T8"/>
<clue>Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that <clueType>includes</clueType> the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.</clue>
</event>
<event id="E68">
<type class="Correlation"/>
<theme idref="A1"/>
<theme idref="T9"/>
<clue>Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that <clueType>includes</clueType> the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term id="T10" lex="Epstein-Barr_virus_oncoprotein" sem="Protein_family_or_group"><term id="T11" lex="Epstein-Barr_virus" sem="Virus">Epstein-Barr virus</term> oncoprotein</term> <term id="T12" lex="latent_infection_membrane_protein_1" sem="Protein_molecule">latent infection membrane protein 1</term> (<term id="T13" lex="LMP1" sem="Protein_molecule">LMP1</term>) is a constitutively aggregated <term id="T14" lex="pseudo-tumor_necrosis_factor_receptor" sem="Protein_domain_or_region">pseudo-tumor necrosis factor receptor</term> (<term id="T15" lex="TNFR" sem="Protein_family_or_group">TNFR</term>) that activates <term id="T16" lex="transcription_factor_NF-kappaB" sem="Protein_complex">transcription factor <term id="T17" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term></term> through two sites in its <term id="T18" lex="C-terminal_cytoplasmic_domain" sem="Protein_domain_or_region">C-terminal cytoplasmic domain</term>.</sentence>
<event KT="Fact" id="E5">
<type class="Binding"/>
<theme idref="T13"/>
<clue>The Epstein-Barr virus oncoprotein latent infection membrane protein 1 (LMP1) is a constitutively <clueType>aggregated</clueType> pseudo-tumor necrosis factor receptor (TNFR) that activates transcription factor NF-kappaB through two sites in its C-terminal cytoplasmic domain.</clue>
</event>
<event KT="Fact" id="E6">
<type class="Positive_regulation"/>
<theme idref="T17"/>
<cause idref="T15"/>
<clue>The Epstein-Barr virus oncoprotein latent infection membrane protein 1 (LMP1) is a constitutively aggregated pseudo-tumor necrosis factor receptor (TNFR) that <clueType>activates</clueType> transcription factor NF-kappaB through two sites in its C-terminal cytoplasmic domain.</clue>
</event>
<sentence id="S3"><term id="A2" sem="Protein_domain_or_region">One site</term> is similar to activated <term id="T19" lex="TNFRII" sem="Protein_molecule">TNFRII</term> in associating with <term id="T20" lex="TNFR-associated_factor" sem="Protein_family_or_group"><term id="T21" lex="TNFR" sem="Protein_family_or_group">TNFR</term>-associated factors</term> <term id="T22" lex="TRAF1" sem="Protein_molecule">TRAF1</term> and <term id="T23" lex="TRAF2" sem="Protein_molecule">TRAF2</term>, and the <term id="A3" sem="Protein_domain_or_region">second site</term> is similar to <term id="T24" lex="TNFRI" sem="Protein_molecule">TNFRI</term> in associating with the <term id="T25" lex="TNFRI_death_domain_interacting_protein" sem="Protein_family_or_group"><term id="T26" lex="TNFRI_death_domain" sem="Protein_domain_or_region"><term id="T27" lex="TNFRI" sem="Protein_molecule">TNFRI</term> death domain</term> interacting protein</term> <term id="T28" lex="TRADD" sem="Protein_molecule">TRADD</term>.</sentence>
<event KT="Analysis" id="E8">
<type class="Binding"/>
<theme idref="A2"/>
<theme idref="T22"/>
<clue>One site is similar to activated TNFRII in <clueType><clueKT>associating</clueKT></clueType> <linkTheme>with</linkTheme> TNFR-associated factors TRAF1 and TRAF2, and the second site is similar to TNFRI in associating with the TNFRI death domain interacting protein TRADD.</clue>
</event>
<event KT="Analysis" id="E9">
<type class="Binding"/>
<theme idref="A2"/>
<theme idref="T23"/>
<clue>One site is similar to activated TNFRII in <clueType><clueKT>associating</clueKT></clueType> <linkTheme>with</linkTheme> TNFR-associated factors TRAF1 and TRAF2, and the second site is similar to TNFRI in associating with the TNFRI death domain interacting protein TRADD.</clue>
</event>
<event KT="Other" id="E10">
<type class="Positive_regulation"/>
<theme idref="T19"/>
<clue>One site is similar to <clueType>activated</clueType> TNFRII in associating with TNFR-associated factors TRAF1 and TRAF2, and the second site is similar to TNFRI in associating with the TNFRI death domain interacting protein TRADD.</clue>
</event>
<event KT="Analysis" id="E11">
<type class="Binding"/>
<theme idref="T19"/>
<theme idref="T22"/>
<clue>One site is similar to activated TNFRII in <clueType><clueKT>associating</clueKT></clueType> <linkTheme>with</linkTheme> TNFR-associated factors TRAF1 and TRAF2, and the second site is similar to TNFRI in associating with the TNFRI death domain interacting protein TRADD.</clue>
</event>
<event KT="Analysis" id="E12">
<type class="Binding"/>
<theme idref="T19"/>
<theme idref="T23"/>
<clue>One site is similar to activated TNFRII in <clueType><clueKT>associating</clueKT></clueType> <linkTheme>with</linkTheme> TNFR-associated factors TRAF1 and TRAF2, and the second site is similar to TNFRI in associating with the TNFRI death domain interacting protein TRADD.</clue>
</event>
<event KT="Other" id="E13">
<type class="Binding"/>
<theme idref="T26"/>
<theme idref="T28"/>
<clue>One site is similar to activated TNFRII in associating with TNFR-associated factors TRAF1 and TRAF2, and the second site is similar to TNFRI in associating with the TNFRI death domain <clueType>interacting</clueType> protein TRADD.</clue>
</event>
<event KT="Analysis" id="E14">
<type class="Binding"/>
<theme idref="A3"/>
<theme idref="T28"/>
<clue>One site is similar to activated TNFRII in associating with TNFR-associated factors TRAF1 and TRAF2, and the second site is similar to TNFRI in <clueType><clueKT>associating</clueKT></clueType> <linkTheme>with</linkTheme> the TNFRI death domain interacting protein TRADD.</clue>
</event>
<event KT="Analysis" id="E15">
<type class="Binding"/>
<theme idref="T24"/>
<theme idref="T28"/>
<clue>One site is similar to activated TNFRII in associating with TNFR-associated factors TRAF1 and TRAF2, and the second site is similar to TNFRI in <clueType><clueKT>associating</clueKT></clueType> <linkTheme>with</linkTheme> the TNFRI death domain interacting protein TRADD.</clue>
</event>
<sentence id="S4"><term id="T29" lex="TNFRI" sem="Protein_molecule">TNFRI</term> has been recently shown to activate <term id="T30" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> through association with <term id="T31" lex="TRADD" sem="Protein_molecule">TRADD</term>, <term id="T32" lex="RIP" sem="Protein_molecule">RIP</term>, and <term id="T33" lex="TRAF2" sem="Protein_molecule">TRAF2</term>; activation of the <term id="T34" lex="NF-kappaB-inducing_kinas" sem="Protein_molecule"><term id="T35" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>-inducing kinase</term> (<term id="T36" lex="NIK" sem="Protein_molecule">NIK</term>); activation of the <term id="T37" lex="IkappaB_alpha_kinase" sem="Protein_family_or_group">IkappaB alpha kinases</term> (<term id="T38" lex="IKKalpha" sem="Protein_molecule">IKKalpha</term> and <term id="T39" lex="IKKbeta" sem="Protein_complex">IKKbeta</term>); and phosphorylation of <term id="T40" lex="IkappaB_alpha" sem="Protein_molecule">IkappaB alpha</term>.</sentence>
<event KT="Analysis" Source="Other" id="E16">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<cause idref="E19"/>
<clue>TNFRI has been <clueSource>recently</clueSource> <clueKT>shown</clueKT> to <clueType>activate</clueType> NF-kappaB <linkCause>through</linkCause> association with TRADD, RIP, and TRAF2; activation of the NF-kappaB-inducing kinase (NIK); activation of the IkappaB alpha kinases (IKKalpha and IKKbeta); and phosphorylation of IkappaB alpha.</clue>
</event>
<event KT="Analysis" Source="Other" id="E17">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<cause idref="E20"/>
<clue>TNFRI has been <clueSource>recently</clueSource> <clueKT>shown</clueKT> to <clueType>activate</clueType> NF-kappaB <linkCause>through</linkCause> association with TRADD, RIP, and TRAF2; activation of the NF-kappaB-inducing kinase (NIK); activation of the IkappaB alpha kinases (IKKalpha and IKKbeta); and phosphorylation of IkappaB alpha.</clue>
</event>
<event KT="Analysis" Source="Other" id="E18">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<cause idref="E21"/>
<clue>TNFRI has been <clueSource>recently</clueSource> <clueKT>shown</clueKT> to <clueType>activate</clueType> NF-kappaB <linkCause>through</linkCause> association with TRADD, RIP, and TRAF2; activation of the NF-kappaB-inducing kinase (NIK); activation of the IkappaB alpha kinases (IKKalpha and IKKbeta); and phosphorylation of IkappaB alpha.</clue>
</event>
<event KT="Analysis" id="E19">
<type class="Binding"/>
<theme idref="T29"/>
<theme idref="T31"/>
<clue>TNFRI has been recently shown to activate NF-kappaB through <clueType><clueKT>association</clueKT></clueType> <linkTheme>with</linkTheme> TRADD, RIP, and TRAF2; activation of the NF-kappaB-inducing kinase (NIK); activation of the IkappaB alpha kinases (IKKalpha and IKKbeta); and phosphorylation of IkappaB alpha.</clue>
</event>
<event KT="Analysis" id="E20">
<type class="Binding"/>
<theme idref="T29"/>
<theme idref="T32"/>
<clue>TNFRI has been recently shown to activate NF-kappaB through <clueType><clueKT>association</clueKT></clueType> <linkTheme>with</linkTheme> TRADD, RIP, and TRAF2; activation of the NF-kappaB-inducing kinase (NIK); activation of the IkappaB alpha kinases (IKKalpha and IKKbeta); and phosphorylation of IkappaB alpha.</clue>
</event>
<event KT="Analysis" id="E21">
<type class="Binding"/>
<theme idref="T29"/>
<theme idref="T33"/>
<clue>TNFRI has been recently shown to activate NF-kappaB through <clueType><clueKT>association</clueKT></clueType> <linkTheme>with</linkTheme> TRADD, RIP, and TRAF2; activation of the NF-kappaB-inducing kinase (NIK); activation of the IkappaB alpha kinases (IKKalpha and IKKbeta); and phosphorylation of IkappaB alpha.</clue>
</event>
<event KT="Analysis" Source="Other" id="E2">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<cause idref="E22"/>
<clue>TNFRI has been <clueSource>recently</clueSource> <clueKT>shown</clueKT> to <clueType>activate</clueType> NF-kappaB <linkCause>through</linkCause> association with TRADD, RIP, and TRAF2; activation of the NF-kappaB-inducing kinase (NIK); activation of the IkappaB alpha kinases (IKKalpha and IKKbeta); and phosphorylation of IkappaB alpha.</clue>
</event>
<event KT="Analysis" Source="Other" id="E3">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<cause idref="E23"/>
<clue>TNFRI has been <clueSource>recently</clueSource> <clueKT>shown</clueKT> to <clueType>activate</clueType> NF-kappaB <linkCause>through</linkCause> association with TRADD, RIP, and TRAF2; activation of the NF-kappaB-inducing kinase (NIK); activation of the IkappaB alpha kinases (IKKalpha and IKKbeta); and phosphorylation of IkappaB alpha.</clue>
</event>
<event KT="Analysis" Source="Other" id="E4">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<cause idref="E24"/>
<clue>TNFRI has been <clueSource>recently</clueSource> <clueKT>shown</clueKT> to <clueType>activate</clueType> NF-kappaB <linkCause>through</linkCause> association with TRADD, RIP, and TRAF2; activation of the NF-kappaB-inducing kinase (NIK); activation of the IkappaB alpha kinases (IKKalpha and IKKbeta); and phosphorylation of IkappaB alpha.</clue>
</event>
<event KT="Analysis" Source="Other" id="E7">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<cause idref="E25"/>
<clue>TNFRI has been <clueSource>recently</clueSource> <clueKT>shown</clueKT> to <clueType>activate</clueType> NF-kappaB <linkCause>through</linkCause> association with TRADD, RIP, and TRAF2; activation of the NF-kappaB-inducing kinase (NIK); activation of the IkappaB alpha kinases (IKKalpha and IKKbeta); and phosphorylation of IkappaB alpha.</clue>
</event>
<event KT="Other" id="E22">
<type class="Positive_regulation"/>
<theme idref="T36"/>
<clue>TNFRI has been recently shown to activate NF-kappaB through association with TRADD, RIP, and TRAF2; <clueType>activation</clueType> <linkTheme>of</linkTheme> the NF-kappaB-inducing kinase (NIK); activation of the IkappaB alpha kinases (IKKalpha and IKKbeta); and phosphorylation of IkappaB alpha.</clue>
</event>
<event KT="Other" id="E23">
<type class="Positive_regulation"/>
<theme idref="T38"/>
<clue>TNFRI has been recently shown to activate NF-kappaB through association with TRADD, RIP, and TRAF2; activation of the NF-kappaB-inducing kinase (NIK); <clueType>activation</clueType> <linkTheme>of</linkTheme> <corefTheme>the IkappaB alpha kinases</corefTheme> (IKKalpha and IKKbeta); and phosphorylation of IkappaB alpha.</clue>
</event>
<event KT="Other" id="E24">
<type class="Positive_regulation"/>
<theme idref="T39"/>
<clue>TNFRI has been recently shown to activate NF-kappaB through association with TRADD, RIP, and TRAF2; activation of the NF-kappaB-inducing kinase (NIK); <clueType>activation</clueType> <linkTheme>of</linkTheme> <corefTheme>the IkappaB alpha kinases</corefTheme> (IKKalpha and IKKbeta); and phosphorylation of IkappaB alpha.</clue>
</event>
<event KT="Other" id="E25">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T40"/>
<clue>TNFRI has been recently shown to activate NF-kappaB through association with TRADD, RIP, and TRAF2; activation of the NF-kappaB-inducing kinase (NIK); activation of the IkappaB alpha kinases (IKKalpha and IKKbeta); and <clueType>phosphorylation</clueType> <linkTheme>of</linkTheme> IkappaB alpha.</clue>
</event>
<sentence id="S5"><term id="T41" lex="IkappaB_alpha" sem="Protein_molecule">IkappaB alpha</term> phosphorylation on <term id="T42" lex="Ser-32" sem="Amino_acid_monomer">Ser-32</term> and <term id="T43" lex="Ser-36" sem="Amino_acid_monomer">Ser-36</term> is followed by its degradation and <term id="T44" lex="NF-kappaB_activation" sem="Other"><term id="T45" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> activation</term>.</sentence>
<event id="E26">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T41"/>
<site idref="T42"/>
<clue>IkappaB alpha <clueType>phosphorylation</clueType> on Ser-32 and Ser-36 is followed by its degradation and NF-kappaB activation.</clue>
</event>
<event id="E45">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T41"/>
<site idref="T43"/>
<clue>IkappaB alpha <clueType>phosphorylation</clueType> on Ser-32 and Ser-36 is followed by its degradation and NF-kappaB activation.</clue>
</event>
<event id="E27">
<type class="Negative_regulation"/>
<theme idref="T41"/>
<clue>IkappaB alpha phosphorylation on Ser-32 and Ser-36 is followed by its <clueType>degradation</clueType> and NF-kappaB activation.</clue>
</event>
<event id="E28">
<type class="Positive_regulation"/>
<theme idref="T45"/>
<clue>IkappaB alpha phosphorylation on Ser-32 and Ser-36 is followed by its degradation and NF-kappaB <clueType>activation</clueType>.</clue>
</event>
<sentence id="S6">In this report, we show that <term id="T46" lex="NF-kappaB_activation" sem="Other"><term id="T47" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> activation</term> by <term id="T48" lex="LMP1" sem="Protein_molecule">LMP1</term> or by each of its <term id="T49" lex="effector_sites" sem="Protein_domain_or_region">effector sites</term> is mediated by a pathway that includes <term id="T50" lex="NIK" sem="Protein_molecule">NIK</term>, <term id="T51" lex="IKKalpha" sem="Protein_molecule">IKKalpha</term>, and <term id="T52" lex="IKKbeta" sem="Protein_complex">IKKbeta</term>.</sentence>
<event KT="Other" id="E29">
<type class="Positive_regulation"/>
<theme idref="T47"/>
<cause idref="T48"/>
<clue>In this report, we show that NF-kappaB <clueType>activation</clueType> <linkCause>by</linkCause> LMP1 or by each of its effector sites is mediated by a pathway that includes NIK, IKKalpha, and IKKbeta.</clue>
</event>
<event KT="Other" id="E30">
<type class="Positive_regulation"/>
<theme idref="T47"/>
<cause idref="T49"/>
<clue>In this report, we show that NF-kappaB <clueType>activation</clueType> by LMP1 or <linkCause>by</linkCause> each of its effector sites is mediated by a pathway that includes NIK, IKKalpha, and IKKbeta.</clue>
</event>
<event KT="Analysis" id="E31">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<cause idref="T50"/>
<clue>In this report, we <clueKT>show</clueKT> that NF-kappaB activation by LMP1 or by each of its effector sites is <clueType>mediated</clueType> <linkCause>by</linkCause> a pathway that includes NIK, IKKalpha, and IKKbeta.</clue>
</event>
<event KT="Analysis" id="E32">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<cause idref="T50"/>
<clue>In this report, we <clueKT>show</clueKT> that NF-kappaB activation by LMP1 or by each of its effector sites is <clueType>mediated</clueType> <linkCause>by</linkCause> a pathway that includes NIK, IKKalpha, and IKKbeta.</clue>
</event>
<event KT="Analysis" id="E33">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<cause idref="T51"/>
<clue>In this report, we <clueKT>show</clueKT> that NF-kappaB activation by LMP1 or by each of its effector sites is <clueType>mediated</clueType> <linkCause>by</linkCause> a pathway that includes NIK, IKKalpha, and IKKbeta.</clue>
</event>
<event KT="Analysis" id="E34">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<cause idref="T51"/>
<clue>In this report, we <clueKT>show</clueKT> that NF-kappaB activation by LMP1 or by each of its effector sites is <clueType>mediated</clueType> <linkCause>by</linkCause> a pathway that includes NIK, IKKalpha, and IKKbeta.</clue>
</event>
<event KT="Analysis" id="E35">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<cause idref="T52"/>
<clue>In this report, we <clueKT>show</clueKT> that NF-kappaB activation by LMP1 or by each of its effector sites is <clueType>mediated</clueType> <linkCause>by</linkCause> a pathway that includes NIK, IKKalpha, and IKKbeta.</clue>
</event>
<event KT="Analysis" id="E36">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<cause idref="T52"/>
<clue>In this report, we <clueKT>show</clueKT> that NF-kappaB activation by LMP1 or by each of its effector sites is <clueType>mediated</clueType> <linkCause>by</linkCause> a pathway that includes NIK, IKKalpha, and IKKbeta.</clue>
</event>
<sentence id="S7"><term id="T53" lex="dominant_negative_mutant" sem="Protein_family_or_group">Dominant negative mutants</term> of <term id="T54" lex="NIK" sem="Protein_molecule">NIK</term>, <term id="T55" lex="IKKalpha" sem="Protein_molecule">IKKalpha</term>, or <term id="T56" lex="IKKbeta" sem="Protein_complex">IKKbeta</term> substantially inhibited <term id="T57" lex="NF-kappaB_activation" sem="Other"><term id="T58" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> activation</term> by <term id="T59" lex="LMP1" sem="Protein_molecule">LMP1</term> or by each of its <term id="T60" lex="effector_site" sem="Protein_domain_or_region">effector sites</term>.</sentence>
<event KT="Other" id="E37">
<type class="Positive_regulation"/>
<theme idref="T58"/>
<cause idref="T59"/>
<clue>Dominant negative mutants of NIK, IKKalpha, or IKKbeta substantially inhibited NF-kappaB <clueType>activation</clueType> <linkCause>by</linkCause> LMP1 or by each of its effector sites.</clue>
</event>
<event KT="Other" id="E38">
<type class="Positive_regulation"/>
<theme idref="T58"/>
<cause idref="T59"/>
<clue>Dominant negative mutants of NIK, IKKalpha, or IKKbeta substantially inhibited NF-kappaB <clueType>activation</clueType> by LMP1 or <linkCause>by</linkCause> each of its effector sites.</clue>
</event>
<event Manner="High" id="E39">
<type class="Negative_regulation"/>
<theme idref="E37"/>
<cause idref="T53" idref1="T54"/>
<clue>Dominant negative mutants of NIK, IKKalpha, or IKKbeta <clueManner>substantially</clueManner> <clueType>inhibited</clueType> NF-kappaB activation by LMP1 or by each of its effector sites.</clue>
</event>
<event Manner="High" id="E40">
<type class="Negative_regulation"/>
<theme idref="E37"/>
<cause idref="T53" idref1="T55"/>
<clue>Dominant negative mutants of NIK, IKKalpha, or IKKbeta <clueManner>substantially</clueManner> <clueType>inhibited</clueType> NF-kappaB activation by LMP1 or by each of its effector sites.</clue>
</event>
<event Manner="High" id="E41">
<type class="Negative_regulation"/>
<theme idref="E37"/>
<cause idref="T53" idref1="T56"/>
<clue>Dominant negative mutants of NIK, IKKalpha, or IKKbeta <clueManner>substantially</clueManner> <clueType>inhibited</clueType> NF-kappaB activation by LMP1 or by each of its effector sites.</clue>
</event>
<event Manner="High" id="E42">
<type class="Negative_regulation"/>
<theme idref="E38"/>
<cause idref="T53" idref1="T54"/>
<clue>Dominant negative mutants of NIK, IKKalpha, or IKKbeta <clueManner>substantially</clueManner> <clueType>inhibited</clueType> NF-kappaB activation by LMP1 or by each of its effector sites.</clue>
</event>
<event Manner="High" id="E43">
<type class="Negative_regulation"/>
<theme idref="E38"/>
<cause idref="T53" idref1="T55"/>
<clue>Dominant negative mutants of NIK, IKKalpha, or IKKbeta <clueManner>substantially</clueManner> <clueType>inhibited</clueType> NF-kappaB activation by LMP1 or by each of its effector sites.</clue>
</event>
<event Manner="High" id="E44">
<type class="Negative_regulation"/>
<theme idref="E38"/>
<cause idref="T53" idref1="T56"/>
<clue>Dominant negative mutants of NIK, IKKalpha, or IKKbeta <clueManner>substantially</clueManner> <clueType>inhibited</clueType> NF-kappaB activation by LMP1 or by each of its effector sites.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
